初期研修・専門研修

業 績


  ■ 2000年   ■ 2001年   ■ 2002年   ■ 2003年   ■ 2004年   ■ 2005年   ■ 2006年   ■ 2007年
  ■ 2008年   ■ 2009年   ■ 2010年   ■ 2011年   ■ 2012年   ■ 2013年   ■ 2014年   ■ 2015年
  ■ 2016年   ■ 2017年   ■ 2018年   ■ 2019年   ■   ■   ■   ■

■ Neuro-Tokushima achievements 2014

 

1.論文･ 著書など (アルファベット順または五十音順)

1A 英文
1A-a. 原著

  1. Akaike N, Shin MC, Wakita M, Torii Y, Harakawa T, Ginnaga A, Kato K, Kaji R, Kozaki S. Transsynaptic inhibition of spinal transmission by A2 botulinum toxin. J Physiol 2013; 591(Pt 4): 1031-1043.
    PubMed

  2. Arii Y, Sawada Y, Kawamura K, Miyake S, Taichi Y, Izumi Y, Kuroda Y, Inui T, Kaji R, Mitsui T. Immediate effect of spinal magnetic stimulation on camptocormia in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2014; 85(11): 1221-1226.
    PubMed

  3. Carosi L, Giudice TL, Lullo MD, Lombardi F, Babalini C, Gaudiello F, Marfia GA, Massa R, Kawarai T, Orlacchio A. Hereditary spastic paraplegia: a novel mutation and expansion of the phenotype variability in SPG10. J Neurol Neurosurg Psychiatry. 2014, in press.
    PubMed

  4. Fujita K, Furukawa T, Matsuoka T, Osaki Y, Izumi Y, Kaji R. Selenium deficiency presenting visual disturbance and myelopathy. Neurol Clin Neurosci 2014; 2: 60-61.
    PubMed

  5. Fujita K, Tanaka K, Takahashi Y. Neuronal antibodies in Creutzfeldt-Jakob disease. JAMA Neurol 2014; 71: 514.
    PubMed

  6. Furukawa T, Matsui N, Fujita K, Miyashiro A, Nodera H, Izumi Y, Shimizu F, Miyamoto K, Takahashi Y, Kanda T, Kusunoki S, Kaji R. Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy. J Neurol Sci 2014; 346(1-2): 75-79.
    PubMed

  7. Giudice TL, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A. Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol. 2014; 261: 518-539. 
    PubMed

  8. Kamada M, Izumi Y, Ayaki A, Nakamura M, Kagawa S, Kudo E, Sako W, Maruyama H, Nishida Y, Kawakami H, Ito H, Kaji R. Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation. Neuropathology 2014; 34(1): 64-70.
    PubMed

  9. Kimura Y, Mihara M, Kawarai T, Kishima H, Sakai N, Takahashi PM and Mochizuki H. Efficiency of deep brain stimulation in an adolescent patient with DYT11 myoclonus-dustonia. Neurology and Clinical Neuroscience 2014; 2: 57-59.
    PubMed

  10. Koizumi H, Goto S, Okita S, Morigaki R, Akaike N, Torii Y, Harakawa T, Ginnaga A, Kaji R. Spinal central effects of peripherally applied botulinum neurotoxin A in comparison between its subtypes A1 and A2. Front Neurol. 2014; 5: 98.
    PubMed

  11. Kokunai Y, Nakata T, Furuta M, Sakata S, Kimura H, Aiba T, Yoshinaga M, Osaki Y, Nakamori M, Itoh H, Sato T, Kubota T, Kadota K, Shindo K, Mochizuki H, Shimizu W, Horie M, Okamura Y, Ohno K, Takahashi MP. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibition effect on Kir2.1. Neurology 2014; 82(12): 1058-1064.
    PubMed

  12. Kumar KR, Lohmann K, Masuho I, Miyamoto R, Ferbert A, Lohnau T, Kasten M, Hagenah J, Bruggemann N, Graf J, Munchau A, Kostic VS, Sue CM, Domingo AR, Rosales RL, Lee LV, Freimann K, Westenberger A, Mukai Y, Kawarai T, Kaji R, Klein C, Martemyanov KA, Schmidt A. Mutations in GNAL: a novel cause of craniocervical dystonia. JAMA Neurol. 2014; 71(4): 490-494.
    PubMed

  13. Matsui N, Ohigashi I, Tanaka K, Sakata M, Furukawa T, Nakagawa Y, Kondo K, Kitagawa T, Yamashita S, Nomura Y, Takahama Y, Kaji R. Increased number of Hassall’s corpuscles in myasthenia gravis patients with thymic hyperplasia. J Neuroimmunol 2014; 269(1-2): 56-61.
    PubMed

  14. Miyamoto R, Koizumi H, Morino H, Kawarai T, Maruyama H, Mukai Y, Miyashiro A, Sako W, Izumi Y, Kawakami H, Kaji R. DYT6 in Japan-genetic screening and clinical characteristics of the patients. Mov Disord. 2014; 29(2): 278-280.
    PubMed

  15. Miyamoto R, Morino H, Yoshizawa A, Miyazaki Y, Maruyama H, Murakami N, Fukada K, Izumi Y, Matsuura S, Kaji R, Kawakami H. Exome sequencing reveals a novel MRE11 mutation in a patient with progressive myoclonic ataxia. J Neurol Sci. 2014; 337(1-2): 219-23.
    PubMed

  16. Miyashiro A, Matsui N Shimatani Y, Nodera H, Izumi Y, Kuwabara S, Imai T, Baba M, Komori T, Sonoo M, Mezaki T, Kawamata J, Hitomi T, Kohara N, Arimura K, Hashimoto S, Arisawa K, Kusunoki S, Kaji R; Japanese Multifocal Motor Neuropathy Study Group.? Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan. Muscle Nerve 2014; 49(3): 357-361.
    PubMed

  17. Miyazaki Y, Sako W, Sato K, Izumi Y, Kaji R. MIBG Myocardial Scintigraphy can Predict the Occurrence of Wearing-off Phenomenon in Early-stage Parkinson’s Disease . J Neurol Disord 2014; 2: 154.
    PubMed

  18. Mori A, Nodera H, Takamatsu N, Shimatani Y, Maruyama K, Oda M, Izumi Y, Kaji R. Focal nerve enlargement is not the cause for increased distal motor latency in ALS: Sonographic evaluation. Clin Neurophysiol. 2014, in press.
    PubMed

  19. Morino H, Miyamoto R, Ohnishi S, Maruyama H, Kawakami H. Exome sequencing reveals a novel TTC19 mutation in an autosomal recessive spinocerebellar ataxia patient. BMC Neurol. 2014; 14: 5.
    PubMed

  20. Mukai Y, Shimatani Y, Sako W, Asanuma K, Nodera H, Sakamoto T, Izumi Y, Kohda T, Kozaki S, Kaji R. Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals. Toxicon. 2014; 81: 32-6.
    PubMed

  21. Mungunkhuyag M, Harada M, Abe T, Fujita K, Matsui N, Kaji R. Longitudinal Monitaring with Multiple MR techniques in a case of progressive multifocal leukoencephalopathy associated with multiple myeloma. Magn Reson Med Sci 2014; 13(1): 55-59.
    PubMed

  22. Mure H, Morigaki R, Koizumi H, Okita S, Kawarai T, Miyamoto R, Kaji R, Nagahiro S, Goto S. Deep brain stimulation of the thalamic ventral lateral anterior nucleus for DYT6 dystonia. Stereotact Funct Neurosurg. 2014; 92(6): 393-396.
    PubMed

  23. Nodera H, Takamatsu N, Shimatani Y, Mori A, Sato K, Oda M, Terasawa Y, Izumi Y, Kaji R. Thinning of cervical nerve roots and peripheral nerves in ALS as measured by sonography. Clin Neurophysiol. 2014; 125(9): 1906-11.
    PubMed

  24. Obayashi M, Stevanin G, Synofzik M, Monin ML, Duyckaerts C, Sato N, Streichenberger N, Vighetto A, Desestret V, Tesson C, Wichmann HE, Illig T, Huttenlocher J, Kita Y, Izumi Y, Mizusawa H, Schols L, Klopstock T, Brice A, Ishikawa K, Durr A. Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion. J Neurol Neurosurg Psychiatry 2014, in press.
    PubMed

  25. Osaki Y, Takamatsu N, Shimatani Y, Mori A, Maruyama K, Miyazaki Y, Nodera H, Kaji R. Ultrasonographic evaluation of myokymic discharges. Clin Neurophysiol. 2014, in press.
    PubMed

  26. Sako W, Murakami N, Izumi Y, Kaji R. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis. Mov Disord 2014; 29(13): 1599-1605.
    PubMed

  27. Sako W, Murakami N, Izumi Y, Kaji R. The difference in putamen volume between MSA and PD: evidence from a meta-analysis. Parkinsonism Relat Disord 2014; 20(8): 873-877.
    PubMed

  28. Sako W, Ishimoto S. Can cystatin C in cerebrospinal fluid be a biomarker for amyotrophic lateral sclerosis? A lesson from previous studies. Neurol Clin Neurosci 2014; 2: 72-75.
    PubMed

  29. Sako W, Murakami N, Izumi Y, Kaji R. MRI can detect nigral volume loss in patients with Parkinson’s disease: evidence from a meta-analysis. J Parkinsons Dis 2014; 4(3): 405-411.
    PubMed

  30. Sako W, Miyazaki Y, Izumi Y, Kaji R. Which target is best for Parkinson’s disease? A meta-analysis of pallidal and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2014; 85(9): 982-986.
    PubMed

  31. Shimatani Y, Nodera H, Shibuta Y, Miyazaki Y, Misawa S, Kuwabara S, Kaji R. Abnormal gating of axonal slow potassium current in cramp-fasciculation syndrome. Clin Neurophysiol. 2014, in press.
    PubMed

  32. Shimizu F, Omoto M, Sano Y, Mastui N, Miyashiro A, Tasaki A, Maeda T, Koga M, Kaji R, Kanda T. Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier. J Neurol Neurosurg Psychiatry. 2014; 85(5): 526-537.
    PubMed

  33. Tada Y, Satomi J, Abe T, Kuwayama K, Sogabe S, Fujita K, Yamamoto N, Kaji R, Harada M, Nagahiro S.Intra-Arterial Signal on Arterial Spin Labeling Perfusion MRI to Identify the Presence of Acute Middle Cerebral Artery Occlusion. Cerebrovasc Dis 2014; 38: 191-196
    PubMed

  34. Takeuchi T, Miyamoto R, Osaki Y, Takasaki T, Yamamoto N, Sato K, Fujita K, Izumi Y, Kaji R. Slow mandibulo-faciolingual wiggling tremor associated with Japanese encephalitis. Movmnt Disords Clncl Practice 2014; 1: 368-370
    PubMed

  35. Tanabe A, Yamamura Y, Kasahara J, Morigaki R, Kaji R, Goto S. A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease. Front Cell Neurosci 2014; 8: 50.
    PubMed

  36. Terasawa Y, Yamamoto N, Morigaki R, Fujita K, Izumi Y, Satomi J, Harada M, Nagahiro S, Kaji R. Brush sign on 3-T T2*-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy. Stroke 2014; 45: 274-276.
    PubMed

  37. Vo A, Sako W, Dewey SL, Eidelberg D, Ulu? AM. 18FDG-microPET and MR DTI findings in Tor1a+/- heterozygous knock-out mice. Neurobiol Dis 2014, in press.
    PubMed

  38. Vo A, Sako W, Niethammer M, Carbon M, Bressman S, Ulu? AM, Eidelberg D. Thalamocortical connectivity correlates with phenotypic variability in dystonia. Cereb Cortex 2014, in press.
    PubMed

  39. Watanabe H, Atsuta N, Nakamura R, Hirakawa A, Watanabe H, Ito M, Senda J, Katsuno M, Izumi Y, Morita M, Tomiyama H, Taniguchi A, Aiba I, Abe K, Mizoguchi K, Oda M, Kano O, Okamoto K, Kuwabara S, Hasegawa K, Imai T, Aoki M, Tsuji S, Nakano I, Kaji R, Sobue G. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014, in press.
    PubMed

  40. Yagi R, Miyamoto R, Morino H, Izumi Y, Kuramochi M, Kurashige T, Maruyama H, Mizuno N, Kurihara H, Kawakami H. Detecting gene mutations in Japanese Alzheimer's patients by semiconductor sequencing. Neurobiol Aging. 2014;35(7):1780.e1-5.
    PubMed

  41. Yamamoto N, Terasawa Y, Satomi J, Morigaki R, Fujita K, Harada M, Izumi Y, Nagahiro S, Kaji R. Reversibility of ischemic findings on 3-tesla magnetic resonance T2(*)-weighted image after recanalization. Reversibility of ischemic findings on 3-tesla magnetic resonance T2*-weighted image after recanalization. J Med Invest. 2014;61(1.2):190-196.
    PubMed

  42. Yamamoto N, Terasawa Y, Satomi J, Sakai W, Harada M, Izumi Y, Nagahiro S, Kaji R. Predictors of neurologic deterioration in patients with small-vessel occlusion and infarcts in the territory of perforating arteries. J Stroke Cerebrovasc Dis. 2014;23(8):2151-2155.
    PubMed

  43. Yamamoto N, Satomi J, Harada M, Izumi Y, Nagahiro S, Kaji R. Is the Susceptibility Vessel Sign on 3-Tesla Magnetic Resonance T2*-Weighted Imaging a Useful Tool to Predict Recanalization in Intravenous Tissue Plasminogen Activator? Clin Neuroradiol. 2014, in press.
    PubMed

  44. Yamamoto N, Terasawa Y, Satomi J, Morigaki R, Fujita K, Harada M, Izumi Y, Nagahiro S, Kaji R. Reversibility of ischemic findings on 3-tesla magnetic resonance T2*-weighted image after recanalization. J Med Invest 2014; 61: 190-196.
    PubMed

1A-b. 総説および抄録

  1. Nodera H, Manto M. Cerebellum tunes the excitability of the motor system: evidence from peripheral motor axons. Cerebellum. 2014 Dec;13(6): 663-5.